251300-30-8

Basic information

• Product Name: 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde
• Synonyms: 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde;5-Bromo-3-(trifluoromethyl)salicylaldehyde;5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde 99%;5-Bromo-3-(trifluoromethyl)salicylaldehyde, 5-Bromo-3-formyl-2-hydroxybenzotrifluoride;5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde99%
• CAS NO: 251300-30-8
• Molecular Formula: C₈H₄BrF₃O₂
• Molecular Weight: 269.0153696
• Mol File: 251300-30-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde(251300-30-8)
• EPA Substance Registry System: 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde(251300-30-8)

Safety Data

• Hazardous Substances Data: 251300-30-8(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde is a chemical compound with the molecular formula C8H5BrF3O2. It is an aromatic aldehyde with a substituent of a bromine atom, a hydroxyl group, and a trifluoromethyl group. 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde is often used as a building block in organic synthesis and pharmaceutical research. It has been studied for its potential applications in medicinal chemistry due to its unique structure and properties. 5-Bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde may also have uses in material science and agrochemicals. Its distinct molecular structure and functional groups make it a useful tool for creating diverse and complex molecules with specific properties and potential biological activities.

Upstream product

• 444-30-4 2-(trifluoromethyl)phenol 
• 336628-66-1 2-(methoxymethoxy)-3-(trifluoromethyl)benzaldehyde 
• 336628-65-0 2-(methoxymethoxy)-1-(trifluoromethyl)benzene 
• 336628-67-2 2-hydroxy-3-(trifluoromethyl)benzaldehyde 
• 50824-04-9 4-bromo-2-(trifluoromethyl)phenol 
• 100-97-0 hexamethylenetetramine 

Downstream Products

• 1285573-52-5 5-bromo-2-methoxy-3-trifluoromethylbenzaldehyde 
• 1285572-57-7 3-(3-cyano-4-hydroxy-5-trifluoromethylbenzoyl)-1,1-dioxo-1,2-dihydro-3H-1,3-benzothiazole 
• 1285573-58-1 5-bromo-1-diethoxymethyl-2-methoxy-3-trifluoromethylbenzene 
• 1285573-63-8 3-formyl-4-methoxy-5-trifluoromethylbenzoic acid 
• 1285573-65-0 5-cyano-4-methoxy-3-trifluoromethylbenzoic acid 
• 1285573-68-3 3-cyano-4-methoxy-5-trifluoromethylbenzoyl chloride 
• 1285573-71-8 3-(3-cyano-4-methoxy-5-trifluoromethylbenzoyl)-2,3-dihydro-1,3-benzothiazole 
• 1285573-75-2 3-(3-cyano-4-methoxy-5-trifluoromethylbenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285572-59-9 3-(3-cyano-4-hydroxy-5-trifluoromethylbenzoyl)-1,2-dihydro-3H-1,3-benzothiazole 
• 1285572-60-2 3-(3-cyano-4-hydroxy-5-trifluoromethylbenzoyl)-1-oxo-2,3-dihydro-1,3-benzothiazole 
• 1285573-78-5 3-(3-cyano-4-methoxy-5-trifluoromethylbenzoyl)-1-oxo-2,3-dihydro-1,3-benzothiazole 
• 1285573-05-8 3-(3-dimethylcarbamoyl-4-hydroxy-5-trifluoromethylbenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole 
• 1285575-54-3 methyl 3-formyl-4-methoxy-5-trifluoromethyl benzoate 
• 1360620-64-9 4-methoxy-5-trifluoromethylisophthalic acid-1-methyl ester 

Relevant articles and documents

ORAL COMPLEMENT FACTOR D INHIBITORS

Disclosed are compounds of formula (I), and pharmaceutically acceptable salts thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant complement system activity.

N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and compounds I for use to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (A) : or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (A), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.